Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q1 2027 Jul 31, 2026 | Q4 2026 Apr 30, 2026 | Q3 2026 Jan 31, 2026 | Q2 2026 Oct 31, 2025 | Q1 2026 Jul 31, 2025 | Q4 2025 Apr 30, 2025 | Q3 2025 Jan 31, 2025 | Q2 2025 Oct 31, 2024 | Q1 2025 Jul 31, 2024 | Q4 2024 Apr 30, 2024 | Q3 2024 Jan 31, 2024 | Q2 2024 Oct 31, 2023 | Q1 2024 Jul 31, 2023 | Q4 2023 Apr 30, 2023 | Q3 2023 Jan 31, 2023 | Q2 2023 Oct 31, 2022 | Q1 2023 Jul 31, 2022 | Q4 2022 Apr 30, 2022 | Q3 2022 Jan 31, 2022 | Q2 2022 Oct 31, 2021 | Q1 2022 Jul 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 4.36M | 4.87M | 7.13M | 8.52M | 10.33M | 9.79M | 3.2M | 2.75M | 2.89M | 2.62M | 4.47M | 5.51M | 4.87M | 10.12M | 11.65M | 10.83M | 8.06M | 9.01M | 8.7M | 4.78M | 4M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | -434K | 212K | -1.33M | 196K | 196K | 185K | 185K | 185K | 185K | 185K | 185K | 185K | 184K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 86K |
Receivables | 13.6M | 13.18M | 12.07M | 11.54M | 9.47M | 11.23M | 15.78M | 10.47M | 9.03M | 9.53M | 7.9M | 7.72M | 8.95M | 8.01M | 8.05M | 8.95M | 9.36M | 9.51M | 8.56M | 8.19M | 7.73M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.33M | 1.17M | 991K | 1.28M | 1.22M | 1.35M | 713K | 860K | 1.25M | 1.5M | 835K | 780K | 1.11M | 1.33M | 661K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 19.29M | 19.22M | 20.19M | 21.33M | 21.01M | 22.37M | 19.7M | 14.08M | 13.18M | 13.64M | 13.2M | 14.02M | 14.92M | 19.46M | 20.36M | 20.61M | 18.37M | 19.66M | 17.83M | 13.7M | 12.6M |
Property-Plant & Equipment | 14.1M | 7.22M | 9.26M | 8.3M | 9M | 9.46M | 10.41M | 10.64M | 11.24M | 11.97M | 13.07M | 13.76M | 14.47M | 14.5M | 15.44M | 15.41M | 15.67M | 15.36M | 15.41M | 15.24M | 15.09M |
Goodwill & Intangibles | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K |
Total Long-Term Assets | 14M | 7.77M | 8.26M | 8.83M | 9.53M | 9.98M | 10.93M | 11.16M | 11.76M | 12.49M | 13.59M | 14.28M | 14.98M | 14.85M | 15.79M | 15.76M | 16.02M | 15.71M | 15.76M | 15.59M | 15.51M |
Total Assets | 33.29M | 26.99M | 28.45M | 30.16M | 30.55M | 32.34M | 30.63M | 25.24M | 24.93M | 26.13M | 26.79M | 28.29M | 29.91M | 34.31M | 36.15M | 36.36M | 34.39M | 35.38M | 33.58M | 29.3M | 28.11M |
Account Payables | 8.31M | 6.9M | 5.73M | 5.99M | 4.85M | 4.25M | 5.09M | 4.85M | 5.24M | 5.8M | 4.76M | 4.54M | 5.76M | 5.33M | 4.3M | 4.61M | 2.54M | 2.87M | 3.74M | 3.48M | 3.35M |
Deferred Revenue | 9.55M | 8.83M | 10M | 12.34M | 14.43M | 15.44M | 10.92M | 10.22M | 10.31M | 12.09M | 13.33M | 12.97M | 11.14M | 12.78M | 13.16M | 11.19M | 10.89M | 11.07M | 8.7M | 6.13M | 5.48M |
Short-Term Debt | 869K | 1.6M | 1.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 2.59M | 3.35M | 97K | 116K | 135K | 154K | 151K | 151K | 150K | 149K | 148K | 146K | 145K | 144K | 143K | 142K | 72K | 15K | 15K | 15K |
Total Current Liabilities | 18.73M | 19.92M | 20.68M | 22.14M | 22.7M | 23.85M | 19.87M | 18.86M | 19.16M | 21.54M | 21.97M | 20.95M | 20.38M | 21.73M | 20.8M | 18.74M | 16.62M | 17.48M | 15.5M | 12.47M | 11.68M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 7K | n/a | 46K | 66K | 85K | 285K | 324K | 363K | 401K | 439K | 476K | 514K | 551K | 588K | 624K | 660K | 391K | 231K | 235K | 242K |
Total Long-Term Liabilities | 10.1M | 3M | 3.39M | 3.79M | 4.31M | 4.72M | 5.29M | 5.7M | 6.1M | 6.49M | 6.88M | 7.25M | 7.62M | 7.94M | 8.29M | 8.46M | 8.79M | 8.8M | 8.85M | 8.76M | 8.89M |
Total Liabilities | 28.83M | 22.92M | 24.07M | 25.93M | 27.01M | 28.57M | 25.16M | 24.56M | 25.27M | 28.04M | 28.85M | 28.2M | 28M | 29.68M | 29.09M | 27.19M | 25.41M | 26.28M | 24.35M | 21.23M | 20.57M |
Total Debt | 10.97M | 4.6M | 5M | 5.27M | 5.75M | 6.11M | 6.44M | 6.78M | 7.11M | 7.43M | 7.74M | 8.05M | 8.35M | 8.6M | 8.87M | 8.97M | 9.23M | 9.47M | 9.63M | 9.46M | 9.51M |
Book Value | 4.46M | 4.07M | 4.38M | 4.23M | 3.54M | 3.77M | 5.47M | 681K | -332K | -1.9M | -2.06M | 93K | 1.9M | 4.64M | 7.06M | 9.17M | 8.98M | 9.1M | 9.24M | 8.07M | 7.54M |
Book Value Per Share | 0.32 | 0.29 | 0.32 | 0.29 | 0.26 | 0.27 | 0.38 | 0.05 | -0.02 | -0.14 | -0.15 | 0.01 | 0.14 | 0.34 | 0.52 | 0.68 | 0.66 | 0.67 | 0.64 | 0.55 | 0.56 |
Common Stock | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 13K |
Retained Earnings | -81.49M | -81.07M | -80.4M | -80.12M | -80.36M | -79.89M | -78.06M | -82.55M | -83.28M | -84.59M | -84.48M | -81.95M | -79.88M | -77.32M | -74.76M | -72.32M | -72.3M | -71.98M | -71.64M | -72.43M | -72.7M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 3.89M | 3.94M | 4.28M | 4.17M | 3.51M | 3.77M | 5.47M | 681K | -332K | -1.9M | -2.06M | 93K | 1.9M | 4.64M | 7.06M | 9.17M | 8.98M | 9.1M | 9.24M | 8.07M | 7.54M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CSBR